A recession usually spells trouble for corporate profits and consumer spending, but Morgan Stanley sees a downturn as a ...

Morgan Stanley sees a more "synchronous" earnings recovery for the U.S. ahead, aided by Fed rate cuts next year, dollar weakness and broader AI gains.

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Incyte Corporation (NASDAQ:INCY) with a price target of $68 ...

Investing in the stock market can help generate wealth. With thousands of stocks available, it can become difficult to cherry ...

Morgan Stanley has reduced its price target on The Campbell’s Company (NASDAQ:CPB) to $35 from $40, maintaining an Equal ...

Morgan Stanley analyst Sanjit Singh raised the price target for Couchbase Inc. (NASDAQ:BASE) to $19 from $18, while maintaining an Equal Weight rating on the stock. This decision comes after Couchbase ...

Shares of Eternal Ltd (formerly Zomato) rallied over 5 per cent intraday on Thursday, June 5, to hit a high of Rs 258.3 on ...

AI data centers are expected to consume a massive amount of energy in the coming years, and meeting the need could be a boon ...

Morgan Stanley named Nvidia its "top pick" among semiconductor stocks Tuesday, a day before the chipmaker's expected earnings ...

Stocks have recouped their losses since April 2, but Morgan Stanley‘s Lisa Shalett says tariff-related hurdles remain. She thinks another year of blockbuster returns in the stock market is unlikely.

A dip in the stock market caused by the Moody’s downgrade of the U.S. debt should be bought, according to a once-pessimistic and now seemingly bullish strategist.